<DOC>
	<DOCNO>NCT02407821</DOCNO>
	<brief_summary>In study investigator hypothesize antidepressant therapy may improve overall welling patient acute chronic kidney disease give around time start chronic dialysis therapy . This study pilot , randomize control trial aim examine whether prescribe oral escitalopram incident dialysis patient safe feasible .</brief_summary>
	<brief_title>The Routine Use SSRI 's Initiation End-stage Renal Disease Treatment ( RoSIE )</brief_title>
	<detailed_description>Over 120,000 people kidney disease start chronic dialysis therapy across North America year . In addition high mortality , study uniformly report high rate depression , pain non-specific symptom dialysis start . Suicide rate high , particularly early treatment history , withdrawal dialysis increasingly common recent year , suggest high burden depressive symptom . While various treatment appear effective , multiple barrier prevent patient get accept appropriate care depression . The investigator hypothesize antidepressant therapy may improve morbidity mortality prescribe patient acute chronic kidney disease ( CKD ) around time start chronic dialysis therapy . This phase II , multi-centre , double blind , randomize control trial compare safety feasibility oral escitalopram placebo incident dialysis patient . Those start chronic dialysis therapy within 12 week identify eligible study . Participants randomize 1:1 receive either escitalopram placebo daily 26 week . The primary outcome feasibility term recruitment rate protocol compliance . The secondary outcome include estimate safety ( adverse event ) efficacy ( hospitalization day , mortality , change depression quality life score ) . This pilot trial intend guide inform design full scale study evaluate whether routine use escitalopram improve quality life hospital free day patient dialysis , compare placebo .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>1 . Male Female age ≥ 25 year 2 . Patient substitute decision maker willing able give inform consent 3 . Incident dialysis define within 12week window first dialysis treatment ( 1 week prior , 11 week ) . Patients forms dialysis except CRRT ( include peritoneal dialysis , home hemodialysis , incentre intermittent hemodialysis nocturnal dialysis ) eligible . Patients return dialysis transplant graft loss eligible . 1 . Past history allergy , intolerance , escitalopram 2 . Known severe hepatic dysfunction 3 . Recent history active bleeding within past 3 month ( e.g . gastrointestinal bleeding require hospitalization ) know bleed disorder 4 . Current use class I antiarrhythmic medication ; SSRI SNRI antidepressant ; pimozide , MAO inhibitor , reserpine , guanethidine , cimetidine methyldopa , omeprazole ; tricyclic tetracyclic antidepressant , neuroleptic anticonvulsant , triptans , tramadol , linezolid , tryptophan , St. John 's Wort ; gabapentin 5 . Past treatment failure depression escitalopram ≥ 2 antidepressant treatment least 6 week duration 6 . Initiation psychotherapy depression 3 month prior study entry 7 . Alcohol substance abuse dependence require acute detoxification study entry 8 . Present past psychosis bipolar disorder , schizophrenia psychotic disorder document medical record 9 . Suicidal ideation define patient significant risk suicide Columbia Suicide Scale71 attempt suicide within 6 month prior Screening Visit 10 . Clinicallyidentified major depressive disorder , opinion clinical team , require treatment 11 . Pregnancy , lactation woman childbearing potential use adequate contraception 12 . Abnormal QTc baseline : QTcF interval &gt; 600 m ( base Fredericia correction QTcF = QT/RR0.33 ) 66 13 . Lactose intolerance ( placebo contains lactose ) 14 . Known uncontrolled glaucoma 15 . Patients require treatment continuous renal replacement therapy ( CRRT ) 16 . Documented history brain tumour</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Controlled Clinical Trials , Randomized</keyword>
	<keyword>Kidney Failure</keyword>
	<keyword>Renal Insufficiency , Chronic</keyword>
	<keyword>Dialysis , Renal</keyword>
	<keyword>Peritoneal Dialysis</keyword>
	<keyword>Hemodialysis</keyword>
	<keyword>Depressive Symptoms</keyword>
	<keyword>Selective Serotonin Reuptake Inhibitors</keyword>
	<keyword>Antidepressants</keyword>
	<keyword>Escitalopram</keyword>
</DOC>